93 related articles for article (PubMed ID: 1434116)
1. Active cutaneous anaphylaxis (ACA) in the mouse ear.
Inagaki N; Miura T; Nagai H; Koda A
Jpn J Pharmacol; 1992 Jun; 59(2):201-8. PubMed ID: 1434116
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of mouse ear PCA.
Inagaki N; Goto S; Nagai H; Koda A
Int Arch Allergy Appl Immunol; 1985; 78(2):113-7. PubMed ID: 2864316
[TBL] [Abstract][Full Text] [Related]
3. Simple spectrophotometric analysis of passive and active ear cutaneous anaphylaxis in the mouse.
Teshima R; Akiyama H; Akasaka R; Goda Y; Toyoda M; Sawada J
Toxicol Lett; 1998 Mar; 95(2):109-15. PubMed ID: 9635414
[TBL] [Abstract][Full Text] [Related]
4. A method for evaluating anti-allergic drugs by simultaneously induced passive cutaneous anaphylaxis and mediator cutaneous reactions.
Koda A; Miura T; Inagaki N; Sakamoto O; Arimura A; Nagai H; Mori H
Int Arch Allergy Appl Immunol; 1990; 92(3):209-16. PubMed ID: 1703513
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of passive cutaneous anaphylaxis (PCA) by azelastine: dissociation of its antiallergic activities from antihistaminic and antiserotonin properties.
Chand N; Harrison JE; Rooney SM; Sofia RD; Diamantis W
Int J Immunopharmacol; 1985; 7(6):833-8. PubMed ID: 3935586
[TBL] [Abstract][Full Text] [Related]
6. [Antigenicity study of carboplatin in guinea pigs and mice].
Kawano S; Kohmura H; Ohta S; Takahashi N
J Toxicol Sci; 1988 Jul; 13 Suppl 2():1-21. PubMed ID: 3054128
[TBL] [Abstract][Full Text] [Related]
7. [Antigenicity study of buspirone hydrochloride in guinea pigs and mice].
Kawano S; Kohmura H; Ohta S; Takahashi N
J Toxicol Sci; 1990 Apr; 15 Suppl 1():15-30. PubMed ID: 2376868
[TBL] [Abstract][Full Text] [Related]
8. [Antigenicity study of paclitaxel].
Kawano S; Ishikawa K; Kohmura H; Kadota T; Takahashi N
J Toxicol Sci; 1994 Aug; 19 Suppl 1():113-22. PubMed ID: 7966458
[TBL] [Abstract][Full Text] [Related]
9. Mouse paw anaphylaxis.
Kaneta S; Ishizuki S; Fujihira E; Mitsuya M
J Immunol Methods; 1984 Jun; 71(1):83-95. PubMed ID: 6144711
[TBL] [Abstract][Full Text] [Related]
10. [Antigenicity tests of suplatast tosilate (IPD-1151T)].
Kouchi Y; Ohuchida A; Maeda Y; Katayama S; Kurokawa M; Mizumoto T; Nakagawa M; Manabe H; Sugimoto S; Yoshida R
J Toxicol Sci; 1992 May; 17 Suppl 2():221-33. PubMed ID: 1321263
[TBL] [Abstract][Full Text] [Related]
11. Effects of different drugs on passive cutaneous anaphylaxis elicited in the mouse ear at 1.5 hours.
Inagaki N; Nagai H; Xu QA; Daikoku M; Nakatomi I; Koda A
Int Arch Allergy Appl Immunol; 1988; 86(2):157-61. PubMed ID: 2455688
[TBL] [Abstract][Full Text] [Related]
12. A study on antigenicity of recombinant human interferon alpha A (LBD-007) in mice and guinea pigs.
Park JI; Han SS; Roh JK; Paik SG
J Toxicol Sci; 1993 Jun; 18 Suppl 2():77-82. PubMed ID: 8355292
[TBL] [Abstract][Full Text] [Related]
13. Effect of CV-3988, a specific antagonist against platelet activating factor, on homologous passive cutaneous anaphylaxis in the mouse ear.
Inagaki N; Miura T; Ohira K; Nagai H; Xu QA; Koda A
J Pharmacobiodyn; 1990 May; 13(5):272-7. PubMed ID: 2177106
[TBL] [Abstract][Full Text] [Related]
14. Orally supplemented Lactobacillus acidophilus strain L-92 inhibits passive and active cutaneous anaphylaxis as well as 2,4-dinitroflurobenzene and mite fecal antigen induced atopic dermatitis-like skin lesions in mice.
Shah MM; Miyamoto Y; Yamada Y; Yamashita H; Tanaka H; Ezaki T; Nagai H; Inagaki N
Microbiol Immunol; 2010 Sep; 54(9):523-33. PubMed ID: 20840151
[TBL] [Abstract][Full Text] [Related]
15. Antigenicity tests on propiverine hydrochloride in guinea pigs and mice.
Kouchi Y; Imamura K; Izumi K; Yoshida R
J Toxicol Sci; 1989 May; 14(2):143-51. PubMed ID: 2778854
[TBL] [Abstract][Full Text] [Related]
16. Induction of IL-4-dependent, anaphylactic-type and IL-4-independent, non-anaphylactic-type IgG1 antibodies is modulated by adjuvants.
Faquim-Mauro EL; Macedo MS
Int Immunol; 2000 Dec; 12(12):1733-40. PubMed ID: 11099313
[TBL] [Abstract][Full Text] [Related]
17. The effects of chlorpheniramine and antiallergic drugs on Ascaris suum antigen-induced active cutaneous anaphylaxis in dogs.
Misawa M; Takenouchi K; Sato M; Yanaura S
Jpn J Pharmacol; 1987 May; 44(1):101-4. PubMed ID: 2442443
[TBL] [Abstract][Full Text] [Related]
18. Antiallergic activity and mode of action of N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(6-methyl-3- pyridyl)acrylamide in experimental animals.
Ishii K; Yakuo I; Seto Y; Kita A; Nakamura H; Nishikawa Y
Arzneimittelforschung; 1993 Feb; 43(2):148-54. PubMed ID: 7681286
[TBL] [Abstract][Full Text] [Related]
19. Regulation of anaphylactic IgG1 antibody production by IL-4 and IL-10.
Silva AS; Cavalcante LT; Faquim-Mauro EL; Macedo MS
Int Arch Allergy Immunol; 2006; 141(1):70-8. PubMed ID: 16804329
[TBL] [Abstract][Full Text] [Related]
20. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on bronchial and cutaneous allergic responses to ascaris in dogs.
Misawa M; Ohmori S; Yanaura S
Arzneimittelforschung; 1986 Nov; 36(11):1647-50. PubMed ID: 2434112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
